Our previous research combined this strategy with a novel Drosophila-based screening method and reported moxifloxacin, a fluoroquinolone antibiotic, to be an effective SMN2 Ex7 splicing booster in SMA patient fibroblasts [15]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.